Home » Topics » Regulatory » Patents

Patents
RSS

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Takeda describes GnRH antagonists

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...